CC
Callan Capital Portfolio holdings
AUM
$1.35B
This Quarter Return
+18.5%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$399M
AUM Growth
+$399M
(+23%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
69.06%
Holding
88
New
7
Increased
32
Reduced
28
Closed
1
Top Buys
Top Sells
| 1 |
iShares Russell 1000 ETF
IWB
|
$26.7M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$24.5M |
| 3 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
$13.3M |
| 4 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
$13.3M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
$5.73M |
Sector Composition
| 1 | Technology | 3.19% |
| 2 | Consumer Discretionary | 0.86% |
| 3 | Communication Services | 0.66% |
| 4 | Consumer Staples | 0.39% |
| 5 | Financials | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Merck
MRK
$210B
| $291K | 0.07% | 3,762 | – | – |
|
77
Visa
V
$683B
| $277K | 0.07% | 1,433 | – | – |
|
78
Meta Platforms (Facebook)
META
$1.86T
| $270K | 0.07% | +1,190 | New | +$270K |
|
79
Texas Instruments
TXN
$184B
| $270K | 0.07% | 2,128 | – | – |
|
80
Target
TGT
$43.6B
| $269K | 0.07% | 2,243 | – | – |
|
81
Amgen
AMGN
$155B
| $237K | 0.06% | 1,005 | – | – |
|
82
McCormick & Company Non-Voting
MKC
$18.9B
| $229K | 0.06% | +1,276 | New | +$229K |
|
83
PepsiCo
PEP
$204B
| $217K | 0.05% | 1,637 -44 | -3% | -$5.83K |
|
84
iShares MSCI Japan ETF
EWJ
$15.3B
| $207K | 0.05% | +3,775 | New | +$207K |
|
|
EVFM
85
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $142K | 0.04% | +50,000 | New | +$142K |
|
86
Standard BioTools
LAB
$481M
| $70K | 0.02% | 17,400 +7,400 | +74% | +$29.8K |
|
87
iShares US Energy ETF
IYE
$1.2B
| – | – | -10,679 | Closed | -$163K |
|